- ►nih.gov S Otani, T Sakurai, K Yamamoto, T Fujita, Y … - British Medical Journal, 2006 - bjo.bmj.com Methods: Autoantigens recognised by immunoglobulin G antibodies (IgG Ab) in sera
from VKH patients were isolated by screening the lambda phage cDNA libraries
made from melanocytes and a highly pigmented melanoma cell line with the ... Cited by 12 - Related articles - BL Direct - All 6 versions
JH Tsai, M Evans, NA Rao - American journal of ophthalmology, 2006 - Elsevier Diagnosis of VKH is dependent on clinical history, findings, and ancillary
testing, as referenced in both sets of criteria. However, the major and minor
symptoms in the Sugiura system limit the diagnosis to patients presenting ... Cited by 5 - Related articles - All 14 versions
FTBGC da Silva, FM Damico, ML Marin, AC … - American Journal of Ophthalmology, 2009 - Elsevier PURPOSE: To evalulate the applicability of the Revised Diagnostic Criteria for
Vogt-Koyanagi-Harada (VKH) disease to Brazilian patients and to verify the
association between different disease categories, clinical parameters, and ... Cited by 4 - Related articles - All 2 versions
K Ohta, N Yoshimura - Ocular Immunology and Inflammation, 2002 - informahealthcare.com Abstract Purpose: To determine whether Bcl-2 is expressed on CD4+ lymphocytes in
the aqueous humor (AH) and cerebrospinal fluid (CSF) of patients with
Vogt-Koyanagi-Harada (VKH) disease, and to determine whether Fas will ... Cited by 5 - Related articles - BL Direct - All 4 versions
PS Prasad, RD Levinson - Clinical Immunology, 2005 - Elsevier We evaluated peptides demonstrated to be immunogenic in studies of
HLA-DRB1*0405-restricted T cells from patients with Vogt–Koyanagi–Harada
(VKH) disease for likelihood of binding to HLA-DRB1*0405 using internet- ... Cited by 5 - Related articles - All 3 versions
RW Read, F Yu, M Accorinti, B Bodaghi, SP … - American journal of ophthalmology, 2006 - Elsevier The Oral only group comprised 15 patients (31%) and the IV+Oral group 33
patients (69%). Median follow-up was 15 months. There was no difference in
duration of follow-up between groups (P = .234). There was no difference in ... Cited by 18 - Related articles - All 14 versions
V Touitou, C Escande, B Bodaghi, N Cassoux, … - Journal français d'ophtalmologie, 2005 - ncbi.nlm.nih.gov PURPOSE: To determine the most efficient diagnostic tools in
Vogt-Koyanagi-Harada syndrome, taking into account the international diagnostic
criteria, and to evaluate the therapeutic management of these patients. ... Cited by 15 - Related articles
- ►iovs.org FM Damico, E Cunha-Neto, AC Goldberg, LK … - Investigative ophthalmology & visual science, 2005 - ARVO METHODS. Peripheral blood mononuclear cells (PBMC) proliferation and Th1 (IFN- )
and Th2 (IL-4 and IL-5) cytokine production were analyzed in
HLA-DRB1*0405-positive (n = 12) and -negative (n = 22) patients with VKH ... Cited by 22 - Related articles - All 3 versions
IH Cardoso, ME Zajdenweber, C Muccioli, LP … - Arquivos Brasileiros de Oftalmologia, 2008 - SciELO Brasil Aplicabilidade do critério diagnóstico revisado de 2001 em pacientes
brasileiros com doença de Vogt-Koyanagi-Harada ... Trabalho realizado no setor
de Úvea e AIDS da Univer- sidade Federal de São Paulo - UNIFESP - São ... Cited by 2 - Related articles - View as HTML - All 7 versions
- ►nih.gov - Free from Publisher M Kitamura, N Kitaichi, M Takeuchi, H … - British Journal of Ophthalmology, 2005 - bjo.bmj.com Background/aims: Advanced glycation end products (AGEs) are considered to act as
mediators of both age related pathologies and diabetic complications. It was
recently reported that glyceraldehyde derived AGE (AGE-2) has a strong ... Cited by 2 - Related articles - BL Direct - All 8 versions
